{"podcast":{"title":"Oakland News Today | 2 Min News | The Daily News Now!","slug":"oakland-news-today-2-min-news-the-daily-news-now-7561175","podcast_index_feed_id":7561175,"rss_url":"https://feeds.fastcast.ai/the-oakland-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-oakland-daily-news-now.jpg","author":"The Daily News Now!","episode_count":1236,"summary":"Hosted by Corey with the Story, Oakland News Today delivers daily coverage of everything happening in Oakland with fast, focused updates on local news, government, business, public safety, weather, and the stories shaping the city. From breaking developments to community updates, the show keeps you informed on what matters most. Each short episode highlights what matters most—including key updates, local trends, and citywide stories—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, Oakland News Today is built for listeners who want reliable local news every single day. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-24T22:19:43.890936+00:00","page_url":"https://stenobird.com/podcast/oakland-news-today-2-min-news-the-daily-news-now-7561175"},"episode":{"title":"GLP-1 Drugs: Weight Loss or Healthcare Crisis | Oakland News","slug":"glp-1-drugs-weight-loss-or-healthcare-crisis-oakland-news","published_at":"2026-07-24T17:53:42+00:00","page_url":"https://stenobird.com/podcast/oakland-news-today-2-min-news-the-daily-news-now-7561175/glp-1-drugs-weight-loss-or-healthcare-crisis-oakland-news","show_page_url":"https://stenobird.com/podcast/oakland-news-today-2-min-news-the-daily-news-now-7561175","url":"https://sources.thednn.ai/a6fcd66b918df249","audio_url":"https://api.fastcast.ai/audio/876ee869-cc3f-4d66-8f8b-7de760fca441.mp3","summary":"GLP-1 drugs like Ozempic, originally for diabetes, are skyrocketing in popularity for weight loss—usage among non-diabetics jumped 600% between 2017 and 2022. While patients pay less out of pocket, overall costs for insurers and government programs have surged 157%, likely driving up premiums and deductibles for everyone. Researchers warn this trend could lead to higher taxes and broader healthcare costs, as the economic ripple effects of this medical breakthrough begin to strain the system. With data from over 20 million adults, experts are calling for smarter, more affordable solutions to balance innovation with accessibility. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/a6fcd66b918df249","meta_description":"GLP-1 drugs like Ozempic, originally for diabetes, are skyrocketing in popularity for weight loss—usage among non-diabetics jumped 600% between 2017 and 2…","key_points":[],"chapters":[],"topics":[],"duration_seconds":99,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/oakland-news-today-2-min-news-the-daily-news-now-7561175/episodes/glp-1-drugs-weight-loss-or-healthcare-crisis-oakland-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/oakland-news-today-2-min-news-the-daily-news-now-7561175/glp-1-drugs-weight-loss-or-healthcare-crisis-oakland-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}